Image-Guided Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas

Abstract

This study demonstrates the clinical usefulness of image-guided fractionated stereotactic radiosurgery with the CyberKnife system. Twenty-one patients with pituitary adenomas received image-guided stereotactic radiosurgery with the CyberKnife, and were followed up for more than 18 months. The patients consisted of 14 with non-functioning adenomas, 3 with prolactinomas, 2 with acromegaly, and 2 with ACTH-producing tumors. In 20 cases, fractionated radiosurgery was performed. The change in the tumor volume, visual acuity, hormonal function, and complications by this therapy were analyzed in each case. The volume of the tumors ranged from 0.2 cm³ to 34.9 cm³ (mean ± SD: 11.3 ± 9.2 cm³). The mean volumes of the non-functioning and functioning adenomas were 13.3 cm³ and 7.5 cm³, respectively. The marginal irradiation dose ranged from 6.4 Gy to 27.7 Gy (mean: non-functioning adenomas 12.6 Gy, functioning adenomas 17.5 Gy), as a dose of a single fraction. The follow-up periods ranged from 18 months to 59 months (mean ± SD: 35.3 ± 10.7 months). The tumor control rate was 95.2 %. In 1 case, visual acuity worsened due to cystic enlargement of the tumor. Hormonal function improved in all of the 7 functioning adenomas. The hormone level normalized in 1 prolactinoma, and decreased to less than normal in 1 ACTH-producing adenoma. In 2 cases, hypopituitarism occurred after the therapy. Image-guided stereotactic radiosurgery with the CyberKnife is effective and safe against relatively large pituitary adenomas. Careful long-term follow-up of the patients is necessary because of delayed cystic enlargement of the tumor in rare cases.

Pituitary adenoma - CyberKnife - fractionation - radiosurgery

References

• 1 Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K. Gamma knife radiosurgery for pituitary adenomas.  J Neurosurg (Suppl 3). 2000;  93 19-22
• 2 Landolt A M, Lomax N. Gamma knife radiosurgery for prolactinomas.  J Neurosurg (Suppl 3). 2000;  93 14-18
• 3 Pan L, Zhang N, Wang E M, Wang B J, Dai J Z, Cai P W. Gamma knife radiosurgery as a primary treatment for prolactinomas.  J Neurosurg (Suppl 3). 2000;  93 10-13
• 4 Sheehan J M, Vance M L, Sheehan J P, Ellegala D B, Law Jr E R. Radiosurgery for Cushing disease after failed transsphenoidal surgery.  J Neurosurg. 2000;  93 738-742
• 5 Zhang N, Pan L, Wang E M, Dai J Z, Wang B J, Cai P W. Radiosurgery for growth hormone-producing pituitary adenomas.  J Neurosurg (Suppl 3). 2000;  93 6-9
• 6 Fukuoka S, Ito T, Takanashi M, Hojo A, Nakamura H. Gamma knife radiosurgery for growth hormone-secreting pituitary adenomas invading the cavernous sinus.  Stereotact Funct Neurosurg. 2001;  76 213-217
• 7 Feigl G C, Bonelli C M, Berghold A, Mokry M. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function.  J Neurosurg (Suppl 5). 2002;  97 415-421
• 8 Kobayashi T, Kida Y, Mori Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results.  J Neurosurg (Suppl 5). 2002;  97 428-433
• 9 Pollock B E, Nippoldt T B, Stafford S L, Foote R L, Abboud C F. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization.  J Neurosurg. 2002;  97 525-530
• 10 Sheehan J P, Kondziolka D, Aickinger J, Lunsfod L D. Radiosurgery for residual or recurrent non-functioning adenoma.  J Neurosurg (Suppl 5). 2002;  97 408-414
• 11 Shin M, Kurita H, Sasaki T, Tago M, Morita A, Ueki K, Kirino T. Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus.  J Neurosurg (Suppl 3). 2002;  93 2-5
• 12 Wowra B, Stummer W. Efficacy of gamma knife radiosugery for non-functioning pituitary adenomas: a quantitative follow-up with magnetic resonance imaging-based volumetric analysis.  J Neurosurg (Suppl 5). 2002;  97 429-432
• 13 Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-Knife radiosurgery in acromegaly: A 4-year follow-up study.  J Clin Endocrinol Metab. 2003;  88 3105-3112
• 14 Petrovich Z, Tu C, Giannotta S, Zee C-S, Appuzo M U. Gamma knife radiosurgery for pituitary adenoma: Early results.  Neurosurgery. 2003;  53 51-61
• 15 Pollock B E, Carpenter P C. Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual non-functioning pituitary adenomas.  Neurosurgery. 2003;  53 1086-1094
• 16 Adler Jr J R, Chang S D, Murphy M J, Doty J, Geis P, Hancock S L. The Cyberknife: a frameless robotic system for radiosurgery.  Stereotact Punct Neurosurg. 1997;  69 124-128
• 17 Chang S D, Murphy M, Geis P, Martin D P, Hancock S L, Doty J R, Adler Jr J R. Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors.  Neurol Med Chir (Tokyo). 1998;  38 780-783
• 18 Chang S D, Adler Jr J R. Robotic and radiosurgery - the cyberknife.  Stereotact Funct Neurosurg. 2001;  76 204-208
• 19 Fowler J E. The linear-quadratic formula and progress in fractionated radiotherapy.  Br J Radiol. 1989;  62 679-694
• 20 Takakura K. Diagnosis of brain tumor. In: The committee of brain tumor registry of Japan (ed). General rules for clinical and pathological studies on brain tumors [in Japanese]. Tokyo: Kanehara Publishing Co. 2002: 62-63
• 21 Chang S D, Main W, Martin D P, Gibbs I C, Heilbrun M P. An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system.  Neurosurgery. 2003;  52 140-146